| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
89,623 |
79,604 |
$50.04M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
44,250 |
38,853 |
$23.30M |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
8,173 |
7,453 |
$5.47M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,842 |
8,079 |
$5.46M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,686 |
4,186 |
$2.49M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,195 |
2,840 |
$2.23M |
| 99442 |
|
3,094 |
2,521 |
$1.72M |
| 99443 |
|
2,686 |
2,049 |
$1.70M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,109 |
1,986 |
$1.51M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,178 |
5,654 |
$1.49M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,526 |
1,452 |
$1.07M |
| 0002A |
|
1,714 |
1,592 |
$976K |
| 0001A |
|
1,675 |
1,575 |
$873K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,054 |
2,817 |
$847K |
| 99441 |
|
1,249 |
1,000 |
$670K |
| 80053 |
Comprehensive metabolic panel |
5,902 |
5,341 |
$655K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,654 |
1,502 |
$585K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,189 |
3,944 |
$527K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,532 |
1,391 |
$454K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,410 |
3,117 |
$418K |
| 99215 |
Prolong outpt/office vis |
698 |
581 |
$369K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
486 |
243 |
$343K |
| 0011A |
|
438 |
410 |
$310K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,314 |
3,928 |
$307K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
353 |
329 |
$248K |
| 0012A |
|
405 |
341 |
$246K |
| 36415 |
Collection of venous blood by venipuncture |
20,855 |
18,370 |
$210K |
| 0004A |
|
557 |
534 |
$186K |
| 0072A |
|
201 |
201 |
$176K |
| 97161 |
|
279 |
270 |
$170K |
| 0071A |
|
268 |
262 |
$160K |
| 92002 |
|
392 |
363 |
$160K |
| 81001 |
|
1,455 |
1,344 |
$152K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,304 |
1,702 |
$145K |
| 92341 |
|
218 |
207 |
$128K |
| 92015 |
Determination of refractive state |
10,001 |
9,181 |
$123K |
| 0003A |
|
226 |
218 |
$114K |
| 71046 |
Radiologic examination, chest; 2 views |
679 |
638 |
$114K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,133 |
1,053 |
$100K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
132 |
125 |
$87K |
| 85018 |
|
660 |
609 |
$86K |
| 90686 |
|
482 |
444 |
$82K |
| 98928 |
|
560 |
499 |
$82K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
130 |
125 |
$76K |
| 90480 |
|
334 |
301 |
$68K |
| 0031A |
|
108 |
107 |
$65K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
147 |
133 |
$56K |
| 87480 |
|
1,410 |
1,321 |
$56K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
85 |
60 |
$46K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
547 |
513 |
$44K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
71 |
62 |
$43K |
| 0124A |
|
99 |
95 |
$43K |
| 0054A |
|
63 |
58 |
$39K |
| 87631 |
|
324 |
303 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
424 |
360 |
$28K |
| 80061 |
Lipid panel |
369 |
350 |
$25K |
| 98968 |
|
50 |
41 |
$25K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
452 |
418 |
$24K |
| 85027 |
|
231 |
212 |
$20K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
78 |
73 |
$17K |
| 90674 |
|
125 |
117 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
344 |
324 |
$14K |
| 90461 |
|
2,130 |
1,987 |
$13K |
| 81025 |
|
366 |
333 |
$12K |
| 0074A |
|
14 |
14 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
32 |
30 |
$11K |
| 0064A |
|
12 |
12 |
$10K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
30 |
14 |
$9K |
| 86580 |
|
13 |
12 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
51 |
30 |
$8K |
| 80306 |
|
21 |
12 |
$7K |
| 86803 |
|
107 |
102 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$6K |
| 82950 |
|
12 |
12 |
$6K |
| 98967 |
|
15 |
13 |
$6K |
| 98940 |
|
184 |
119 |
$6K |
| 83540 |
|
202 |
190 |
$5K |
| 82607 |
|
104 |
98 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,087 |
1,024 |
$4K |
| 20610 |
|
234 |
190 |
$4K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
390 |
240 |
$4K |
| 81003 |
|
95 |
76 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
16 |
12 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,327 |
1,716 |
$3K |
| 0154A |
|
15 |
15 |
$3K |
| 96127 |
|
674 |
576 |
$3K |
| 73630 |
|
14 |
12 |
$2K |
| 87660 |
|
1,400 |
1,305 |
$2K |
| 96380 |
|
16 |
16 |
$1K |
| 86704 |
|
41 |
38 |
$808.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
178 |
169 |
$710.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13 |
12 |
$682.00 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
36 |
29 |
$235.53 |
| G0127 |
Trimming of dystrophic nails, any number |
13 |
13 |
$70.56 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
131 |
120 |
$58.87 |
| 92134 |
|
18 |
14 |
$38.55 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
25 |
24 |
$32.42 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
17 |
16 |
$11.78 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16 |
13 |
$7.39 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
31 |
27 |
$6.51 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
86 |
80 |
$0.68 |
| 87510 |
|
1,409 |
1,319 |
$0.00 |
| 36416 |
|
590 |
543 |
$0.00 |
| 86780 |
|
118 |
113 |
$0.00 |
| 82728 |
|
161 |
150 |
$0.00 |
| T1016 |
Case management, each 15 minutes |
5,396 |
632 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
130 |
125 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
25 |
24 |
$0.00 |
| 83986 |
|
12 |
12 |
$0.00 |
| 90656 |
|
48 |
48 |
$0.00 |
| 90381 |
|
15 |
15 |
$0.00 |
| 87340 |
|
13 |
13 |
$0.00 |
| 90474 |
|
62 |
59 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
45 |
31 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
13 |
$0.00 |
| 87088 |
|
14 |
13 |
$0.00 |
| 86769 |
|
70 |
45 |
$0.00 |
| 86592 |
|
18 |
12 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$0.00 |
| H2021 |
Community-based wrap-around services, per 15 minutes |
6,434 |
1,334 |
$0.00 |
| 98926 |
|
14 |
13 |
$0.00 |
| 91322 |
|
122 |
117 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,021 |
502 |
$0.00 |
| H2015 |
Comprehensive community support services, per 15 minutes |
602 |
197 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
22 |
18 |
$0.00 |
| 84466 |
|
173 |
161 |
$0.00 |
| 99408 |
|
71 |
39 |
$0.00 |
| 99173 |
|
126 |
118 |
$0.00 |
| 98960 |
|
15 |
12 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
28 |
24 |
$0.00 |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
45 |
43 |
$0.00 |
| 90670 |
|
22 |
15 |
$0.00 |